
Guillain-Barre Syndrome Following SARS-CoV-2 Vaccination: A Case Report
Guillain-Barre Syndrome Following SARS-CoV-2 Vaccination: A Case Report
- 대한정신약물학회
- Clinical Psychopharmacology and Neuroscience
- Vol.20 No.4
- : SCOPUS, SCIE, KCI등재
- 2022.11
- 777 - 780 (4 pages)
After more than a year of Coronavirus disease 2019 pandemic, in 2021 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccination have been made possible and vaccine was distributed globally. Since then, there have been reports of symptoms following SARS-CoV-2 vaccination, including neurological symptoms of ascending paralysis known as Guillain-Barre syndrome. In this report, we describe the first case of Guillain-Barre syndrome following vaccination in Indonesia. Symptoms of ascending paralysis were of late onset after the first dose, however, were full blown after receiving the second dose followed by left-sided facial paralysis.
INTRODUCTION
CASE
DISCUSSION
REFERENCES